Join this live webinar to learn more.
As FDA guidance raises expectations for broader access and more representative enrollment, biotech sponsors are being challenged to rethink traditional site feasibility. Historical enrollment metrics within large research centers/providers are no longer enough. Today’s trials must reach patients where they live and that means redefining what “site readiness” truly looks like.
This webinar will explore how community-based research models are reshaping trial planning and execution, including:
Join Syneos Health experts for a practical discussion on building trial strategies that align with regulatory expectations and real-world patient needs.
Offered Free by: Syneos Health
See All Resources from: Syneos Health
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.





